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Lower limb co-contraction during walking in subjects with stroke: a systematic review 1 
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ABSTRACT  3 
Purpose: The aim of this paper was to identify and synthesise existing evidence on lower limb 4 
muscle co-contraction (MCo) during walking in subjects with stroke. 5 
Methods: An electronic literature search on Web of Science, PubMed and B-on was conducted. 6 
Studies from 1999 to 2012 which analysed lower limb MCo during walking in subjects with stroke, 7 
were included.  8 
Results: Eight articles met the inclusion criteria: 3 studied MCo in acute stage of stroke, 3 in the 9 
chronic stage and 2 at both stages. Seven were observational and 1 had a pretest-posttest 10 
interventional design. The methodological quality was “fair to good” to “high” quality (only 1 11 
study). Different methodologies to assess walking and quantify MCo were used. There is some 12 
controversy in MCo results, however subjects with stroke tended towards longer MCo in both lower 13 
limbs in both the acute and chronic stages, when compared with healthy controls. A higher level of 14 
post-stroke walking ability (speed; level of independence) was correlated with longer thigh MCo in 15 
the non-affected limb. One study demonstrated significant improvements in walking ability over 16 
time without significant changes in MCo patterns.  17 
Conclusions: Subjects with stroke commonly present longer MCo during walking, probably in an 18 
attempt to improve walking ability. However, to ensure recommendations for clinical practice, 19 
further research with standardized methodologies is needed. 20 
  21 
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1. Introduction 22 
 23 
Stroke is defined by the World Health Organization as a focal or global neurological 24 
impairment of cerebrovascular cause (Lamontagne et al. 2000; Truelsen et al. 2007). It is one of the 25 
most chronic disabling diseases (Olesen et al. 2003) and the major cause of persistent motor 26 
impairments on one side of the body, which interfere with arm function and the ability to sit up, 27 
stand and walk (Staines et al. 2009).  28 
Walking ability is severely impaired in 25% of people with stroke (Hendricks et al. 2002; 29 
Jang 2010), limiting functional independence and leading to reduced quality of life (Lord et al. 30 
2004). Walking impairment may result from a combination of deficits in perception, muscle 31 
strength, sensation, muscle tone and motor control (Yavuzer 2006; Patterson et al. 2007). A deficit 32 
in motor control is one of the most common walking deficits following stroke (Roerdink et al. 33 
2007). Motor control is the process by which the Central Nervous System (CNS) generates 34 
purposeful and coordinated movements whilst the body interacts with the environment (Latash et al. 35 
2010). This process depends on precisely timed and appropriately modulated synergies between 36 
muscles, including synergies between functionally opposite muscles (agonist and antagonist 37 
muscles) (Latash et al. 2010).  38 
Muscle Co-contraction is the simultaneous activity of agonist and antagonist muscles 39 
crossing the same joint (MCo) (Busse et al. 2005). When agonist/antagonist muscles work 40 
synergistically, the antagonist muscle acts as stabiliser during agonist muscle contraction (Busse et 41 
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al. 2005). This synergy is important for providing optimal joint stability, good movement accuracy 42 
and energy efficiency during functional activities, such walking (Milner 2002; Arias et al. 2012; 43 
Knarr et al. 2012). MCo can be estimated using temporal or magnitude dimensions of 44 
electromyographic (EMG) recordings from the muscles involved (Criswell 2007). Temporal MCo is 45 
defined as the time during which opposing muscles are simultaneously active and is usually 46 
classified using terms such normal, longer or shorter MCo duration. Magnitude of MCo is defined 47 
as the relative magnitude of simultaneous contraction between opposing muscles (Hortobágyi et al. 48 
2009) and is classified using terms such normal, high or reduced magnitude of MCo (Criswell 49 
2007).  50 
Some differences have been found in MCo patterns between subjects with CNS disorders (Hesse et 51 
al. 2000; Lamontagne et al. 2000; Lamontagne et al. 2002; Busse et al. 2005) and healthy subjects 52 
(Den Otter et al. 2004; Prosser et al. 2010) during walking. In healthy subjects, MCo is at a 53 
maximum around the knee in the loading period of gait (e.g., vastus lateralis/medial hamstrings) to 54 
provide increased knee stability (Fonseca et al. 2006) and around the ankle in mid-stance (e.g., 55 
tibialis anterior/soleus) to generate an efficient plantarflexor moment necessary to move the limb 56 
forward efficiently (Fonseca et al. 2006; Sasaki et al. 2009). MCo increases in healthy and impaired 57 
participants whilst learning a new skill (Vereijken et al. 1992) or in the presence of instability 58 
(Nakazawa et al. 2004). However, adverse effects of this increased MCo have been reported, such 59 
as the increase in compressive joint loading and decreased movement flexibility, resulting in 60 
decreased movement adaptability (Busse et al. 2005).  61 
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Busse et al. (Busse et al. 2005) conducted a systematic review of MCo patterns in subjects with 62 
CNS disorders during upper and lower limb tasks, concluding that the most successful rehabilitation 63 
outputs were found in people with MCo patterns similar to those found in healthy subjects. 64 
However, only two studies included in their review assessed MCo during walking in subjects with 65 
stroke. These studies reported increases in inter-subject variability and duration and magnitude of 66 
MCo in subjects with stroke. 67 
 This research therefore systematically identified and synthesised evidence on lower limb 68 
MCo during walking in subjects with stroke.  69 
 70 
2. Methods 71 
 72 
2.1. Research Question 73 
The two main research questions in this study were:  74 
 1. Which MCo patterns characterise the affected and non-affected lower limbs during the 75 
acute and chronic stages of stroke recovery? 76 
 2. How do MCo patterns relate to walking ability? 77 
 78 
2.2. Search strategy 79 
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 The electronic literature search was performed in April 2013 on the following databases: 80 
Web of Science (1970-date), MEDLINE via PubMed (1948-date) and B-on Knowledge Library 81 
(1999-2013). The following search terms were applied: “co-contraction” OR “coactivation” AND 82 
“gait” OR “locomotion” OR “walking” AND “stroke” OR “cerebrovascular disease”. The search 83 
was limited to titles and abstracts. Articles were included if they: (i) studied people with walking 84 
impairment due to stroke and ii) analysed lower limb MCo with surface electromyography (sEMG) 85 
during walking. Articles clearly unrelated to the theme (e.g., did not include subjects with stroke, 86 
assessed activities other than walking), written in languages other than English or Portuguese and 87 
unpublished studies were excluded. Review papers, abstracts of communications or meetings, 88 
papers on conference proceedings, editorials, commentaries to articles and study protocols were not 89 
considered suitable for this review. Nevertheless, their reference lists, in addition to the reference 90 
lists of all included studies, were scanned to find other potentially eligible articles.  91 
 This systematic review was reported according to Preferred Reporting Items for Systematic 92 
Reviews and Meta-Analyzes (PRISMA) guidelines (Moher et al. 2009). The PRISMA guidelines 93 
consist of a 27-item checklist and a four-phase flow diagram to ensure the transparent and complete 94 
reporting of systematic reviews and meta-analyses (Moher et al. 2009).  95 
 96 
2.3. Data extraction 97 
 Data from the included studies was extracted by one reviewer and then checked by a second 98 
reviewer using a data extraction table which identified: author identification, year of publication, 99 
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study design, sample, walking and MCo assessment protocols, muscles assessed, main results for 100 
MCo and walking ability. Muscles assessed were reported in two different categories: muscles of 101 
the affected lower limb and muscles of the non-affected lower limb. In each sub-category, muscles 102 
were classified as thigh or shank muscles.  103 
 104 
2.4. Quality assessment 105 
 The quality of the studies was independently assessed by two reviewers using a modified 106 
version of the scoring system developed by Hailey and co-workers (Hailey D et al. 2004). This 107 
score classifies the studies on 5 levels of quality, from grade A (high quality) to E (poor quality), 108 
according to the study design and characteristics (patient selection, protocol description, statistical 109 
methods and sample size, patient disposal and outcomes reported) (Hailey D et al. 2004). Two 110 
independent reviewers assessed the quality of the studies. Results were compared and differences 111 
were resolved by discussion. 112 
 113 
3. Results 114 
 115 
3.1. Study Selection 116 
 Ninety-nine studies were identified: 34 duplicates were removed. The title and abstract of 65 117 
articles were screened. Fifty-seven articles were excluded as they: (i) did not include subjects with 118 
stroke (n=3), (ii) assessed activities other than walking (n=52) and (iii) were not written in English 119 
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or Portuguese (n= 2). Eight studies addressed MCo during walking in subjects with stroke and were 120 
included in this review (Figure 1). 121 
 122 
Figure 1: Flow diagram according to the different phases of the systematic review as proposed by PRISMA. 123 
3.2. Study Characteristics 124 
 From the included studies, 7 were observational assessing MCo during walking with no 125 
intervention (Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Den Otter 126 
et al. 2006; Den Otter et al. 2007; Chow et al. 2012), one of which was longitudinal (Den Otter et 127 
al. 2006), with data collected at 5 time-points. One study used a pretest-posttest design (Massaad et 128 
al. 2009), assessing walking ability before and after an intervention based on feedback about center 129 
of mass. Three studies included subjects in the acute stage of stroke (Lamontagne et al. 2000; 130 
Lamontagne et al. 2002; Den Otter et al. 2006), 3 in the chronic stage (Detrembleur et al. 2003; 131 
Massaad et al. 2009; Chow et al. 2012) and 2 in both stages (Hesse et al. 1999; Den Otter et al. 132 
2007).  133 
 In total, 142 subjects with stroke (54% male) participated in the included studies. Sample 134 
sizes varied from 6 (Massaad et al. 2009) to 30 patients with stroke (Lamontagne et al. 2000). The 135 
ages ranged from 35 (Hesse et al. 1999) to 81 (Lamontagne et al. 2000) years old. The sample in the 136 
Hesse et al. (Hesse et al. 1999) study was equally distributed in terms of the hemisphere affected 137 
(50% of right hemiparesis); was 43% right hemisphere in the Lamontagne et al (2000); and, was not 138 
described in the other studies. 139 
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Details on the functional status of included stroke subjects are limited in the included 140 
studies. Where functional status is described a range of measures have been used, each with a 141 
different focus, raising difficulties with comparison and synthesis of findings: Fugl-Meyer Scale 142 
(FM) (Lamontagne et al. 2000; Lamontagne et al. 2002), Functional Independent Measure (FIM) 143 
(Detrembleur et al. 2003), Stroke Impairment Assessment Set (SIAS) (Massaad et al. 2009) and 144 
Ashworth Scale (AS) (Detrembleur et al. 2003; Chow et al. 2012).  145 
All except two studies (Hesse et al. 1999; Massaad et al. 2009) included a group of healthy 146 
age and gender-matched controls. Although these two studies do not contribute to our 147 
understanding about how MCo patterns differ between healthy subjects and people post-stroke (1st 148 
review question) they are included in this review because of their analysis exploring relationships 149 
between different MCo patterns and walking ability (functional parameters, e.g. energy cost, 150 
walking speed, temporal symmetry , foot contact, etc.) post-stroke (2nd review question).  151 
 Methodologies used to assess MCo during walking differed between studies: 3 assessed 152 
subjects with stroke walking on the floor (Lamontagne et al. 2000; Lamontagne et al. 2002; 153 
Detrembleur et al. 2003); 3 assessed subjects whilst they were walking on a treadmill (Den Otter et 154 
al. 2006; Den Otter et al. 2007; Massaad et al. 2009)and 1 study compared walking on a treadmill 155 
with body-weight support and walking on the floor (Hesse et al. 1999). In most studies, subjects 156 
were instructed to walk at their normal speed (Hesse et al. 1999; Lamontagne et al. 2000; 157 
Lamontagne et al. 2002; Detrembleur et al. 2003; Den Otter et al. 2007; Massaad et al. 2009; Chow 158 
et al. 2012) and in 1 study to walk at their maximum speed (Den Otter et al. 2006). Distances 159 
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walked by subjects with stroke differed across the studies from 7 (Chow et al. 2012) to 10 meters 160 
(Lamontagne et al. 2000; Lamontagne et al. 2002; Detrembleur et al. 2003) 161 
 The MCo quantification also varied: in 1 study two raters visually inspected the graphs of an 162 
averaged and normalised sEMG signal of two antagonists muscles and classified MCo considering 163 
both temporal and magnitude of MCo (Hesse et al. 1999); 2 studies assessed the time of overlap 164 
between the linear envelopes of antagonists muscles (Lamontagne et al. 2000; Lamontagne et al. 165 
2002) and 4 studies calculated the percentage of gait cycle in which both antagonist muscles were 166 
active based on "onset" sEMG signal determination (Detrembleur et al. 2003; Den Otter et al. 2006; 167 
Den Otter et al. 2007; Massaad et al. 2009). Only 1 study explored the ratio between the temporal 168 
dimension and the magnitude of MCo using automatic computation methods, by implementing the following 169 
formula: the area of overlap between the linear envelopes of antagonists muscles (equivalent to MCo 170 
magnitude , divided by the overlap duration (equivalent to temporal MCo) (Chow et al. 2012).  171 
 172 
3.3. Quality assessment 173 
 The Den Otter et al. study (Den Otter et al. 2006) was the only one rated as A (high quality). 174 
The other 7 studies were rated as C (fair to good quality) (Hesse et al. 1999; Lamontagne et al. 175 
2000; Lamontagne et al. 2002; Detrembleur et al. 2003; Den Otter et al. 2007; Massaad et al. 2009; 176 
Chow et al. 2012).  177 
 178 
3.4. Synthesis of the results 179 
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 The results were organised into three main categories: i) MCo in the affected lower limb 180 
(Figure. 2); ii) MCo in the non-affected lower limb (Figure 2) and iii) MCo and walking ability after 181 
stroke. The first two categories were subdivided into shank and thigh muscles. Table 1 summarizes 182 
the data extracted from the included studies. 183 
 184 
Figure 2: Thigh and shank MCo in both affected and non-affected lower limbs and in acute and chronic stages of recovery after 185 
stroke.  186 
 187 
Table 1: Characteristics of the studies included in the analysis of MCo during walking in subjects with stroke 188 
 189 
3.4.1. MCo patterns in the affected lower limb  190 
 191 
Shank Muscles (affected limb) 192 
 A variety of MCo patterns were identified for the shank muscles of the affected lower limb 193 
in subjects with stroke (Hesse et al. 1999; Lamontagne et al. 2000; Lamontagne et al. 2002; 194 
Detrembleur et al. 2003; Den Otter et al. 2006; Den Otter et al. 2007; Chow et al. 2012). In the 195 
acute stage of stroke recovery, 2 studies reported shank MCo within normal values (Lamontagne et 196 
al. 2002; Den Otter et al. 2006); however, Lamontagne et al. (Lamontagne et al. 2000) found that 197 
subjects with acute stroke tended to present with a shorter MCo (p<0.001) between tibialis anterior 198 
(TA) and gastrocnemius (GAS) during stance phase, when compared to healthy controls.  199 
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 In the chronic stage, subjects with stroke presented longer MCo between the TA and the 200 
medial gastrocnemius (GM) during the whole gait cycle (Detrembleur et al. 2003), with longer and 201 
higher values during the first (p=0.005) and second double support phases (p=0.015) (Chow et al. 202 
2012).  203 
 204 
Thigh Muscles (affected limb) 205 
 MCo values between rectus femoris (RF) and biceps femoris (BF) were longer in subjects 206 
with stroke than in healthy controls (Den Otter et al. 2007) in both acute (Den Otter et al. 2006) and 207 
chronic stages (Detrembleur et al. 2003). This finding was statistically significant during single 208 
stance (63%; p<0.05) in the acute stage (Den Otter et al. 2006). 209 
 210 
3.4.2. MCo patterns in the non-affected lower limb  211 
Shank Muscles (non-affected limb) 212 
 Contradictory findings were found for MCo of the shank in the non-affected lower limb.  213 
Two studies identified statistically significant longer shank (TA/GAS) MCo (Lamontagne et al. 214 
2000; Lamontagne et al. 2002) in subjects in the acute stage of stroke when compared to healthy 215 
controls, specifically during the first and second double support phases (p<0.001) (Lamontagne et 216 
al. 2000) and during the entire stance phase (p<0.05)(Lamontagne et al. 2002). However, Den Otter 217 
et al.(Den Otter et al. 2006), identified non-statistically significant shorter shank (TA/GM) MCo 218 
during the whole gait cycle, in subjects in the acute stage compared to healthy controls.  219 
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 One article reported shank MCo in the chronic stage (Chow et al. 2012) and concluded that 220 
the non-affected lower limb presented with a greater MCo (considering both magnitude and 221 
temporal domain) (Chow et al. 2012) during the first double support phase, when compared to 222 
healthy subjects (p=0.038).  223 
 224 
Thigh Muscles (non-affected limb) 225 
 Thigh MCo between vastus lateralis (VL) and BF of the non-affected lower limb was only 226 
assessed in the acute stage by Den Otter et al.(Den Otter et al. 2006). These authors found a 227 
significantly longer thigh MCo during single stance phase (61%; p<0.05) in subjects with stroke 228 
than in healthy subjects. No data were available for the chronic stage of the disease. 229 
 230 
3.4.3. MCo and walking ability after stroke (both limbs) 231 
 In the included studies, the relationship between MCo and several walking outcomes was 232 
assessed: initial contact pattern (Hesse et al. 1999), energy cost (Detrembleur et al. 2003; Massaad 233 
et al. 2009), total mechanical work (Detrembleur et al. 2003), mobility index, functional ambulation 234 
classification (Den Otter et al. 2006), walking speed (Lamontagne et al. 2000; Den Otter et al. 235 
2006), temporal asymmetry (Den Otter et al. 2006), ankle strength, postural stability (Lamontagne 236 
et al. 2000), plantarflexor and dorsiflexor moments (Lamontagne et al. 2002) and center of mass 237 
displacement (Massaad et al. 2009).  238 
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 Relationships between these variables and MCo in both the affected and non-affected lower 239 
limbs were found. In the affected lower limb, longer shank and thigh MCo was associated with 240 
increased mechanical work (the work performed by muscles) and energy costs (energy 241 
expenditure/walking speed). However, no relationship with work production efficiency (mechanical 242 
work/energy expenditure) was observed (Detrembleur et al. 2003). Normal values of shank MCo 243 
were related to a normal foot position at initial contact (Hesse et al. 1999) and to a higher dynamic 244 
ankle strength, estimated from the peak plantarflexor moment of force during a gait cycle 245 
(Lamontagne et al. 2000). In the study of Massaad et al. (Massaad et al. 2009), both energy cost and 246 
MCo of thigh muscles in both affected and non-affected lower limbs were decreased after an 247 
intervention using center of mass feedback. In the non-affected lower limb, significantly longer 248 
thigh MCo was associated with an improvement in walking speed and higher level of walking 249 
independence (Den Otter et al. 2006). An increase in shank MCo of the non-affected lower limb 250 
was associated with reduced motor ability of the affected lower limb in terms of the plantarflexor 251 
moment (Lamontagne et al. 2002), dynamic ankle strength and postural stability (Lamontagne et al. 252 
2000). Subjects with stroke presenting with measures of postural stability, dynamic ankle strength 253 
(Lamontagne et al. 2000) and temporal asymmetry (Den Otter et al. 2006) close to normal ranges 254 
were those with normal shank MCo in the affected lower limb.  255 
 In the study of Den Otter et al.(Den Otter et al. 2006), subjects with stroke were followed for 256 
10 weeks after walking acquisition and showed a significant improvement in walking speed, general 257 
mobility and ambulatory independence. However, these improvements were not associated with 258 
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significant changes in temporal MCo of thigh or shank muscles which remained longer throughout 259 
the 10 weeks. This study therefore observed that walking recovery was not associated with duration 260 
of MCo.  261 
 262 
Discussion 263 
This systematic review identified and synthesised the existing evidence on lower limb MCo during 264 
walking in subjects with stroke. Only 8 studies were included, and these used a range of different 265 
methods, restricting comparison of the results across studies and the degree of confidence in the 266 
evidence. Nevertheless, this systematic review did enable us to identify some specific trends in the 267 
available MCo data and to explore MCo contribution to the recovery of walking ability post-stroke 268 
as outlined below.  269 
 270 
MCo in the affected lower limb 271 
 Only three studies have explored thigh MCo (Detrembleur et al. 2003; Den Otter et al. 2006; 272 
Den Otter et al. 2007) and six have explored shank MCo (Lamontagne et al. 2000; Lamontagne et 273 
al. 2002; Detrembleur et al. 2003; Den Otter et al. 2006; Den Otter et al. 2007; Chow et al. 2012). 274 
Despite this limited evidence, results suggest specific trends for MCo patterns of subjects with 275 
stroke. 276 
 Longer thigh MCo was observed for single leg stance in the acute stage (Den Otter et al. 277 
2006). It is known that the greatest difficulties in the acute stage are experienced during stance, in 278 
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particular in controlling knee position during loading (Werner et al. 2002). Longer thigh MCo 279 
might, therefore, be an important adaptation strategy in the early days after stroke.  280 
 Longer shank MCo in the chronic stage during double support phase (Chow et al. 2012), 281 
suggests that these muscles may also play an important adaptation role later in stroke recovery 282 
(Detrembleur et al. 2003; Massaad et al. 2009; Chow et al. 2012).Walking places different 283 
functional demands dependent on the stage of recovery. For instance acute patients rarely walk 284 
outside the home, but as recovery occurs, people often commence community walking and thus face 285 
increasing demands due to the variability and uncertainty of the environment. Consequently 286 
different MCo strategies may be required and developed to adapt not only to the differing abilities 287 
but also the varying environments. During the acute stage, people with stroke present significant 288 
weakness in the dorsiflexors (Olney et al. 1996), limiting the ability of these muscles to contribute 289 
to walking stability through MCo. Dorsiflexor strength increases with recovery, enabling the 290 
necessary ankle stability required to walk in community environments which may explain the 291 
finding of increased MCo in the chronic stage. These findings support the idea that MCo after 292 
stroke may represent an important adaptation strategy to enhance a safer gait, producing different 293 
patterns according to different stages of stroke recovery (Paul Cordo et al. 1997).  294 
 295 
MCo in the non-affected lower limb 296 
 Few studies have explored thigh MCo in the non-affected lower limb in the acute stage (Den 297 
Otter et al. 2006; Den Otter et al. 2007) and none in the chronic stage. The longer thigh MCo 298 
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observed during stance can probably be attributed to the need for greater stability (Raja et al. 2012) 299 
required to sustain the prolonged stance phase commonly seen on the non-affected lower limb. This 300 
prolonged stance is often a motor adaptation for the limited efficiency of the affected lower limb to 301 
support body weight (Olney et al. 1996). In general, MCo of the non-affected lower limb can be an 302 
important strategy developed to adapt the walking pattern to physical impairments in the affected 303 
side and therefore, might play an important role in the walking efficiency post-stroke (Buurke et al. 304 
2008). 305 
 Three studies assessing shank MCo of the non-affected lower limb in the acute stage of 306 
recovery produced contradictory results (Lamontagne et al. 2000; Lamontagne et al. 2002; Den 307 
Otter et al. 2006) and only one study explored these muscles in the chronic stage (Chow et al. 308 
2012). Some trends can be observed in acute and chronic stages: longer thigh MCo was identified in 309 
single stance phase in the acute stage (Den Otter et al. 2006) and longer shank MCo was identified 310 
for double support phases in both acute (Lamontagne et al. 2000; Lamontagne et al. 2002) and 311 
chronic stages (Detrembleur et al. 2003; Chow et al. 2012).  312 
 During the double support phase, longer shank MCo might be an adaptation strategy for 313 
disturbed inter-limb coordination and lack of efficiency in weight transference from one lower limb 314 
to another (Geurtsa et al. 2005). Olney et al. (Olney et al. 1996) argued that efficiency in weight 315 
transference depends on good medio-lateral control, obtained through a strong ankle plantarflexor 316 
moment at push-off of the unloading limb. In this way, longer shank MCo during push-off from the 317 
non-affected lower limb may help generate a stronger ankle plantarflexor moment necessary to 318 
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move this limb forward quickly and efficiently thus reducing the duration of loading on the affected 319 
leg. 320 
 321 
 Overall, the findings of this review suggest increased duration of MCo during walking after 322 
stroke in both the affected and non-affected limb, most likely as an adaptation strategy to increase 323 
walking stability. In particular, different patterns were seen for different walking phases and 324 
different muscle groups. This may be indicative of recovery mechanisms, an artifact of the various 325 
methods employed in the studies (e.g. different walking speeds and surfaces) (Gross et al. 2013) or 326 
of confounding factors not carefully addressed in the analysis and interpretation (Zhang et al. 1997). 327 
For instance, walking post-stroke is characterised by significantly slower speeds and high inter-328 
subject variability which will affect stride parameters and consequently MCo patterns (Peterson et 329 
al. 2010; Gross et al. 2013). Slowest walking speeds post-stroke are usually associated with 330 
inability to recruit additional MCo (Gross et al. 2013). MCo patterns seen in subjects with stroke 331 
may therefore be an artifact more reflective of gait speed than any other underlying stroke related 332 
impairment. Therefore, methodologies of analysis that control for the effect of walking speed are 333 
needed to clarify the single contribution of MCo to walking function. Variations in joint position 334 
also impact on muscle length and consequently influence MCo (Zhang et al. 1997). Considering the 335 
high variability in walking patterns and therefore joint positions during post-stroke gait,  (Quervain. 336 
et al. 1996), this presents a further confounding factor which needs to be considered and/or 337 
controlled in future studies.  338 
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 339 
MCo and walking ability after stroke 340 
 The studies in this review identified several relationships between walking ability 341 
parameters and MCo. Subjects with stroke with MCo values within normal ranges in the affected 342 
lower limb tended to exhibit greater walking performance, characterised by more efficient 343 
kinematics patterns (Hesse et al. 1999) and higher dynamic strength (Lamontagne et al. 2000). The 344 
opposite tends to be observed in the non-affected lower limb: walking speed and level of walking 345 
independence were greater in subjects with thigh MCo above normal when compared to healthy 346 
individuals (Den Otter et al. 2006). Findings from the included studies suggest strong relationships 347 
between MCo and kinematics, dynamic strength, postural stability, walking speed and walking 348 
independence in subjects with stroke. Similar relationships have been reported in osteoarthritis 349 
(Heiden et al. 2009), cerebral palsy (Poon et al. 2009) and Parkinson’s disease (Ramsey et al. 2004) 350 
and in healthy elderly people (Melzer et al. 2004). 351 
In addition, longer MCo was reported as being related to increased energy costs of walking. This is 352 
in accordance with previous literature identifying MCo as a costly metabolic process (Missenard et 353 
al. 2008). Despite this, Detrembleur, et al. (Detrembleur et al. 2003) argued that increased MCo in 354 
the non-affected lower limb helps establish a well-balanced efficiency in walking. By increasing 355 
MCo, the non-affected lower limb increases its mechanical work and replaces some of the work that 356 
cannot be performed by the affected lower limb. Therefore, despite MCo being an energy 357 
consuming process, it may help restoring walking efficiency (Detrembleur et al. 2003).  358 
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 Only one longitudinal study explored the relationship between changes in MCo and changes 359 
in walking ability (Den Otter et al. 2006). In this study, subjects with stroke were followed over 10 360 
weeks and a significant improvement in walking ability reported with no significant changes in 361 
temporal MCo. This finding contradicts the associations seen in the observational studies. However, 362 
in the analysis of these results several limitations must be considered. In this study, walking was 363 
assessed on a treadmill at maximum walking speed (which differs from the gait protocol in the other 364 
studies) and may not reflect the natural functional demands which subject’s experience. Therefore, 365 
during this walking assessment, subjects might have exhibited different adaptation strategies from 366 
those developed in daily living conditions (Hesse et al. 1999). Hence, this is an important 367 
methodological limitation. Moreover, only temporal MCo was assessed and its magnitude ignored. 368 
However, for MCo assessment both temporal and magnitude dimensions should be considered as 369 
both are important aspects of motor control (Fonseca et al. 2001). 370 
 371 
Limitations and recommendations for future research 372 
 This review identified some trends in MCo patterns during walking post-stroke and has 373 
found relationships between these patterns and walking ability parameters. However, given the 374 
limited number of studies that have been conducted in this field and their methodological 375 
limitations some inconsistent findings were presented. These methodological limitations include 376 
small sample sizes and lack of standardisation in: walking assessment protocols, the methods for 377 
measuring and analysing MCo and the walking ability outcome measures selected. Moreover, data 378 
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on mean MCo and respective measures of variation were not reported in all studies, instead only 379 
levels of significance were provided. This lack of quantitative MCo data made comparison of 380 
results across studies difficult. Given the small number of studies and the diversity of methods more 381 
research, with standardised designs, is needed to further our understanding of MCo patterns during 382 
walking after stroke. In particular, longitudinal studies exploring changes in MCo over time and the 383 
relationship of these to improvements in walking ability parameters are urgently required. 384 
 385 
Development and validation of methods for MCo assessment during walking in subjects with 386 
stroke 387 
• Application of the ICF Core Set for stroke to characterise the subject´s general functionality 388 
would facilitate the agreement of functional outcomes across studies, providing further 389 
understanding of relationships between MCo patterns and subject´s clinical and functional 390 
status; 391 
• Standardisation of walking protocols (surface, speed, distance) for MCo assessment 392 
purposes would reduce confounding MCo factors when comparing results across studies; 393 
• Adherence to guidelines for sEMG acquisition and analysis would avoid significant 394 
differences in the muscle activity measurement across studies; 395 
• Establishment of an expert working group to generate recommendations about the most 396 
appropriate formulas/computational approaches for MCo quantification in subjects with 397 
stroke would facilitate comparison of MCo across studies; 398 
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 399 
Conclusions 400 
 In this review, subjects with stroke tended to exhibit longer MCo during walking than 401 
healthy controls, however MCo patterns appeared to vary depending on the stage of stroke 402 
recovery. MCo strategies during walking may change to adapt the walking pattern to the different 403 
functional demands specific to acute or chronic stages. These strategies may be developed in both 404 
the affected and non-affected lower limbs, with MCo patterns in the non-affected lower limb 405 
helping to establish normal walking efficiency. Establishing consensus, using robust study designs, 406 
is important for enhancing the design of interventions for walking recovery. 407 
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Author 
(year) 
 
Design 
 
Participants 
 
Walking Assessment 
Protocol 
 
Muscles 
 Results 
MCo Walking Ability 
Affected Lower Limb 
Non Affected Lower 
Limb 
 
Hesse et al. 
(1999)  
Observational 
 
N=18 Subjects  
50% R hemiparesis 
72% MCA; 28% 
SIH 
Acute and chronic 
stages of stroke: 2.9 
to 11.2 months post 
onset 
77% males 
35-77yrs 
 
 
Treadmill (unsupported, 
with 15% of body 
weight support (BWS), 
with 30% of BWS) and 
floor walking (15 
meters); 
Mean velocity = 
0.27m/s;  
 
Shank 
Muscles: 
TA/GAS 
 Higher and longer during 
ground-level walking than 
during treadmill walking with 
body weight support - Gait 
Cycle; 
 A better initial contact (with the sole instead of 
the forefoot) while subjects walked in the 
treadmill with body weight support. 
Lamontagne 
et al.(2000)  
Observational 
  
N=30 Subjects 
43% R hemiparesis 
100% MCA 
FM 22±6 (10-32) 
Acute stage of 
stroke: less than 6 
months post onset 
53% males 
38-81y 
 
N=17 Healthy 
subjects 
52% males 
43-75yrs  
 
 
Walk for 10 meters; 
Subjects with stroke: at 
natural speed; 
Healthy subjects: walk 
at very slow speed; 
 
Shank 
Muscles: 
TA/GAS 
 Significantly shorter (p<0.01) 
during Single Stance; 
 
 
Significantly longer 
(p<0.001) during 1st and 
2nd Double Stance; 
Longer duration (p<0.001) 
during 1st Double Stance; 
Affected Lower Limb: co-contraction durations 
approached normal values as gait speed, 
postural stability and dynamic strength 
increased. 
 
Non Affected Lower Limb: longer co-
contraction was associated with slower gait 
speed (r=0.38*)), poorer postural stability 
(r=0.51**) and lower dynamic ankle strength 
on the paretic side (r=-0.37**). 
 
Lamontagne 
et al. (2002)  
 
Observational 
  
N=30 Subjects  
43% R hemiparesis 
FM 22±6 (10-32) 
Acute stage of 
stroke: less than 6 
months post onset 
70% males 
37-72yrs 
 
N=15 Healthy 
subjects;  
67% males 
Walk along 10 meters; 
Subjects with stroke: at 
natural speed;  
Healthy subjects: 
natural and very slow 
speed;  
Shank 
Muscles: 
TA/GAS 
 Within normal values in SW 
phase + stance phase; 
Significant difference 
between both legs in 1st 
Double Stance + Single 
Stance; 
Longer co-contraction, than 
controls walking at natural 
speed (p<0.05) and at very 
slow speed (p<0.01) during 
-1st Double Stance and 
Single Stance; 
Reduced plantarflexor moment on the affected 
lower limb was combined with excessive 
antagonist co-contraction at the ankle on the 
non-affected lower limb; 
Table 1: Characteristics of the studies included in the analysis of MCo during walking in subjects with stroke 
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43-75yrs 
Detrembleur 
et al. (2003)  
 
Observational 
 
N= 9 Subjects; 
67% R hemiparesis;  
FIM 123 (118-125); 
SIAS (44-68); 
AS (0-3); 
Chronic stage of 
stroke: 6 to 85 
months post onset; 
55% males; 
37-77yrs; 
Walk across 10 meters 
at a comfortable speed 
and at fast speed; 
Thigh 
Muscles: 
RF/BF 
 
 
 
Shank 
Muscles: 
TA/LG 
 Around 10% and 1.5-6 times 
longer than normal during all 
Gait Cycle; 
; 
 
Around 40% and 1.5-6 longer 
than normal during all Gait 
Cycle; 
 
 Increase in muscle co-contraction was 
combined with an increase in energy cost of 
walking (energy expenditure/speed of walking), 
proportional to the increase in the total 
mechanical work (work done by muscles), but 
with normal work production efficiency 
(mechanical work/energy expended). 
Hypothesis to explain normal work production 
efficiency: 
unaffected lower limb performed most of the 
work; 
 
Den Otter et 
al. (2006)  
 
Observational 
  
N= 14 Subjects; 
35.7% R 
hemiparesis; 
42.8% impaired SS; 
78.57% impaired 
TC; 
Acute stage of 
stroke: 23 to 52 days 
post onset;  
43% males 
39-71yrs 
 
N= 14 Healthy 
subjects; 
43% males 
42.8y±12.3yrs 
Walking on a treadmill: 
as early as possible after 
admission; 1, 3, 6 and 
10 weeks after baseline; 
Tested a maximum 
speed (maintained 
during 40sec.); speed 
was increased as much 
as possible;  
 
Thigh 
Muscles:  
BF/RF 
 
 
 
 
 
 
Shank 
Muscles: 
TA/GM 
 Longer (p<0.05) in single 
Stance at baseline; no 
significant change during 
follow up. 
Stroke:63%±34%; 
Healthy:31%±21%; 
 
 
 
Non-statistically different 
from controls during all Gait 
Cycle at baseline; no 
significant differences during 
follow ups. 
 
 
 
Longer (p>0.05) in single 
stance, compared to 
controls during all Gait 
Cycle at baseline; no 
significant change during 
follow up. 
 
Shorter duration (P>0.05) 
during all Gait Cycle at 
baseline; no significant 
differences during follow 
ups. 
 
No changes in temporal asymmetry; 
Walking speed increased over time; 
General mobility (Rivermead Mobility Index) 
of subjects increased over time; 
Subjects ambulatory independence (Functional 
Ambulation Categories) increased over time; 
Den Otter et 
al. 2007 
Observational 
 
N= 24 Subjects; 
58% R hemiparesis; 
37.5% impaired SS; 
67% impaired TC; 
Acute and Chronic 
stages: 3 to 21 
months after stroke; 
42% males 
58.58±13.17yrs 
 
N= 14 Healthy 
Subjects; 
Walking on a treadmill 
for 40s; 
Tests with a self-
selected speed;  
Thigh 
Muscles: 
BF/RF 
 
 
 
Shank 
Muscles: 
TA/GAS 
 Exceed controls levels in 
affected double support 
phase; (p<0.05) 
Stroke: 61%±31; 
 
No significant differences, 
compared with controls; 
 
 
Exceed controls levels; all 
gait cycle; (p<0.05) 
Stroke: 62%±31; 
 
No significant differences, 
compared with controls 
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43% male 
42.85±12.3yrs 
Massaad et 
al.(2009)  
 
Pretest-
Posttest 
 
N= 6 Subjects; 
67% R hemiparesis; 
SIAS (47-67); 
Chronic stage of 
stroke: 48 to 285 
months post onset;  
67% males 
47±13yrs 
18 training sessions: 
- 30 minutes walking in 
a treadmill with 
feedback of the CM 
displacement (3 trials, 
10 minutes each); 
Walking at comfortable 
speed;-walking period 
increased 5 minutes 
every 2 weeks; 
 
Thigh 
Muscles: 
VL/BF 
 
 
 
Shank 
Muscles: 
TA/GM 
 Decreased significantly 
(10%;p=0.026) during all 
Gait Cycle; 
Pre:44%±9 
Post:39%±13 
 
Did not change significantly 
(p=0.516) during all Gait 
Cycle;  
Pre:21%±16 
Post:18%±17 
 
 
Decreased significantly by 
15% (p=0.012) during all 
Gait Cycle;  
Pre:40%±7 
Post:34%±10 
 
Did not change 
significantly (p=0.249) 
during all Gait Cycle;  
Pre27:%±21 
Post:21%±9 
 
Vertical CM displacement decreased; 
Gait energy cost decreased;  
Chow et al.,  
(2012)  
 
Observational 
  
N= 11 Subjects; 
AS 2±0.2 
Chronic stage of 
stroke: 45±46 
months post onset; 
27% males 
41±9 yrs 
 
N= 11 Healthy 
subjects; 
Gender and age 
matched; 
Walking 7 meters (8-10 
times); 
Stroke subjects at a self-
selected speed; 
Healthy subjects at a 
self-selected very slow 
speed; 
 
Shank 
Muscles: 
TA/GM 
 Greater (p=0.001) during 2nd 
Double Stance;  
Greater (p=0.015) during 1st 
Double Stance; 
Greater (p=0.005) during1st  
Double Stance+ Single 
Stance; 
 
Greater compared to 
controls (p=0.038) during 
1st Double Stance; 
 
EMG: electromyography, %: percentage, TA: tibialis anterior, GAS: gastrocnemius,GM: medial gastrocnemius; LG: lateral gastrocnemius; VL: vastus lateralis; BF: biceps femoris, RF: rectus femoris; MCA, 
middle cerebral artery; SIH, supra intracranial hemorrhage; R, right; FM, Fugl-Meyer scale; FIM, Functional Independence Measurement; SIAS, Stroke Impairment Assessment Set; AS, Ashworth Scale; SS, 
sensibility Score; TC, Trunk Control; *statistically significant at p<0.05; ** statistically significant at p<0.001. 
